Bio-Techne Releases Second Quarter Fiscal 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Bio-Techne (TECH) Tops Q2 EPS by 25c
February 2, 2021 6:35 AM ESTBio-Techne (NASDAQ: TECH) reported Q2 EPS of $1.62, $0.25 better than the analyst estimate of $1.37. Revenue for the quarter came in at $224.3 million versus the consensus estimate of $206.48 million.
For earnings history and earnings-related data on Bio-Techne (TECH) click here.
... More